Texas Healthcare and Bioscience Institute Releases Strategic Vision to Advance the Texas Life Sciences Ecosystem

Report highlights the state's rapid growth in bioscience employment, research investment, and innovation while offering recommendations to sustain long-term leadership.

Mar. 30, 2026 at 6:19pm

Got story updates? Submit your updates here. ›

The Texas Healthcare & Bioscience Institute (THBI), the statewide public policy voice of the healthcare and bioscience industry, has released a comprehensive report outlining a strategic vision for strengthening Texas' life sciences and biotechnology ecosystem. The report highlights the scale and momentum of the Texas bioscience sector, including $4.6 billion in bioscience-related academic research and development expenditures in 2022, $1.8 billion in NIH funding awarded to Texas institutions in 2023, and $8.7 billion in venture capital investment raised by Texas bioscience companies between 2019 and 2023.

Why it matters

Texas has emerged as one of the nation's leading bioscience hubs, leveraging its extensive research infrastructure, expanding workforce, and business-friendly environment. The report provides a roadmap for policymakers, industry leaders, researchers, and educators to collaborate in strengthening Texas' global competitiveness in the life sciences and biotechnology industry, which is crucial for driving advancements in healthcare, biotechnology, and economic growth.

The details

The report outlines several policy and ecosystem recommendations designed to strengthen Texas' leadership in life sciences and biotechnology, including modernizing research infrastructure, accelerating the commercialization of discoveries, and expanding access to emerging technologies. The report is being released in conjunction with the annual Texas Life Sciences Summit, hosted by the Texas Healthcare and Bioscience Institute, which will convene leaders from across the healthcare, biotechnology, research, and policy communities to explore the trends, investments, and innovations shaping the future of life sciences in Texas.

  • The report was released on March 30, 2026.
  • The Texas Life Sciences Summit kicks off on March 31, 2026 and runs through April 1, 2026.

The players

Texas Healthcare & Bioscience Institute (THBI)

The statewide public policy voice of the healthcare and bioscience industry in Texas.

Got photos? Submit your photos here. ›

What’s next

The report serves as a foundation for discussions at the Texas Life Sciences Summit, where leaders from across the healthcare, biotechnology, research, and policy communities will explore the trends, investments, and innovations shaping the future of life sciences in Texas.

The takeaway

The report highlights Texas' emergence as a leading bioscience hub and provides a roadmap for policymakers, industry leaders, researchers, and educators to collaborate in strengthening the state's global competitiveness in the life sciences and biotechnology industry, which is crucial for driving advancements in healthcare, biotechnology, and economic growth.